David Kirke

David Kirke is an accomplished executive with extensive experience in the pharmaceutical industry, currently serving as Executive Director at BioMarin Pharmaceutical Inc. since September 2019, following a tenure as Senior Director. Prior roles include Director at UCB Pharma from February 2011 to September 2019, Associate Director at ERA Consulting from April 2008 to February 2011, and Vaccine Development Scientist at Schering-Plough from 2005 to 2008, where work focused on vaccine production processes for bacterial and viral pathogens. Earlier in the career, David was an R&D Scientist at Phico Therapeutics Ltd from 2002 to 2005, contributing to the development of modified bacteriophage viruses. David Kirke earned a PhD in Pharmaceutical Sciences from the University of Nottingham between 1996 and 1999.